. Author manuscript; available in PMC: 2015 Nov 1.

Published in final edited form as: JPEN J Parenter Enteral Nutr. 2014 Jun 4;39(8):929–934. doi: 10.1177/0148607114536580

Table 2.

Univariate Analysis.

Risk Factors	CLABSI (n = 220)	No CLABSI (n = 4620)	P Value
Age, mean (SD), y	62.3 (16.2)	63.5 (16.5)	.27^a
Charlson comorbidity score, mean (SD)	2.8 (2.4)	2.5 (2.4)	.19^a
Duration of PN, mean (SD), d	10.7 (10.2)	15.5 (20.7)	.33^a
Duration of catheterization, mean (SD), d	14.3 (15.3)	8.1 (12.8)	<.0001^a
Male sex, %	58.2	55.0	.35
Underlying disease, %
Malignancy	22.7	20.3	.38^b
Diabetes mellitus	21.8	28.5	.03^b
HIV	2.3	1.7	.43^c
Renal disease	76.8	48.9	<.0001^b
Surgical site infection, %	1.4	2.6	.24
PN, %	8.1	2.3	<.0001^b
History of transplant, %	8.6	5.5	.05^b
ICU stay, %	81.8	59.4	<.0001^b
Immunodeficiency, %	60.0	34.3	<.0001^b
Pneumonia, %	19.1	8.7	<.0001^b

CLABSI, central line–associated bloodstream infection; HIV, human immunodeficiency virus; ICU, intensive care unit; PN, parenteral nutrition; SD, standard deviation.

Student t test.

χ² test.

Fisher exact test.